Ad is loading...
MENU
CGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cognition Therapeutics (CGTX) Ownership - Who owns Cognition Therapeutics?
Profile
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.51M
P/E Ratio
N/A
Total Cash
28.53M
Projected Growth
N/A
Total Debt
809K
Revenue
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash/Share
0.71
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGTX
Capitalization
18.5M
P/E Ratio
N/A
Risk (Beta)
1.35
Dividend Yield
N/A
Total Cash
28.5M
Total Cash/Share
0.71
Total Debt
809K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
23M
P/B Ratio
0.89
Cash Flow
N/A
Earnings
-0.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
40K
Current Ratio
3.07
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-30.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-79.36
Shares Held By Institutions
9.5M
Shares Outstanding - Current
40.1M
Total Liabilities
11.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-75.070
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2500 Westchester Avenue
Phone
+1 412 481-2210
Employees
28
Web
https://www.cogrx.com